VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS20051742 | HPV | ENSG00000140009.19 | protein_coding | ESR2 | No | No | 2100 | Q92731 |
TVIS20022496 | HPV | ENSG00000140009.19 | protein_coding | ESR2 | No | No | 2100 | Q92731 |
TVIS44015404 | HTLV-1 | ENSG00000140009.19 | protein_coding | ESR2 | No | No | 2100 | Q92731 |
TVIS44023634 | HTLV-1 | ENSG00000140009.19 | protein_coding | ESR2 | No | No | 2100 | Q92731 |
TVIS44012773 | HTLV-1 | ENSG00000140009.19 | protein_coding | ESR2 | No | No | 2100 | Q92731 |
TVIS44041591 | HTLV-1 | ENSG00000140009.19 | protein_coding | ESR2 | No | No | 2100 | Q92731 |
TVIS44041670 | HTLV-1 | ENSG00000140009.19 | protein_coding | ESR2 | No | No | 2100 | Q92731 |
TVIS44051073 | HTLV-1 | ENSG00000140009.19 | protein_coding | ESR2 | No | No | 2100 | Q92731 |
TVIS44047171 | HTLV-1 | ENSG00000140009.19 | protein_coding | ESR2 | No | No | 2100 | Q92731 |
TVIS44047121 | HTLV-1 | ENSG00000140009.19 | protein_coding | ESR2 | No | No | 2100 | Q92731 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | ESR2 |
---|---|
DrugBank ID | DB11674 |
Drug Name | Equol |
Target ID | BE0000792 |
UniProt ID | Q92731 |
Regulation Type | agonist |
PubMed IDs | 15084758; 15883431 |
Citations | Mueller SO, Simon S, Chae K, Metzler M, Korach KS: Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci. 2004 Jul;80(1):14-25. Epub 2004 Apr 14.@@Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, Heubi JE: S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005 May;81(5):1072-9. |
Groups | Investigational |
Direct Classification | Isoflavanols |
SMILES | OC1=CC=C(C=C1)[C@H]1COC2=C(C1)C=CC(O)=C2 |
Pathways | |
PharmGKB | |
ChEMBL | CHEMBL198877 |